Related Articles
Bortezomib improves adoptive carbonic anhydrase IX‑specific chimeric antigen receptor‑modified NK92 cell therapy in mouse models of human renal cell carcinoma
Chimeric antigen receptor‑natural killer cells: novel insight into immunotherapy for solid tumors (Review)
Combination of CAR‑T cell therapy and radiotherapy: Opportunities and challenges in solid tumors (Review)
Research advances in chimeric antigen receptor-modified T-cell therapy (Review)
CD19/CD22 bispecific chimeric antigen receptor‑NK‑92 cells are developed and evaluated